Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ghiorzo

Showing results (51-60 of 147) with videos related to

Pageof 15
Sort By:
Melanoma Research|November 10, 2007
The p.G23S CDKN2A founder mutation in high-risk melanoma families from Central ItalyFrancesca Gensini, Roberta Sestini, Mauro Piazzini, et al.
Journal of Translational Medicine|August 27, 2025
Identification of prognostic liquid biopsy biomarkers in patients with cutaneous squamous cell carcinoma treated with cemiplimabI Vanni, M Croce, L Pastorino, et al.
Genes, Chromosomes & Cancer|March 30, 2000
Mutation screening of the CDKN2A promoter in melanoma familiesM Harland, E A Holland, P Ghiorzo, et al.
Pigment Cell & Melanoma Research|November 6, 2008
CDKN2A mutations and MC1R variants in Italian patients with single or multiple primary melanomaL Pastorino, L Bonelli, P Ghiorzo, et al.
Plos One|September 7, 2012
Novel PTCH1 mutations in patients with keratocystic odontogenic tumors screened for nevoid basal cell carcinoma (NBCC) syndromeLorenza Pastorino, Annamaria Pollio, Giovanni Pellacani, et al.
Oncotarget|January 1, 2017
Heterogeneity and frequency of BRAF mutations in primary melanoma: Comparison between molecular methods and immunohistochemistryWilliam Bruno, Claudia Martinuzzi, Virginia Andreotti, et al.
International Journal of Cancer|October 3, 1999
Characterization of ligurian melanoma families and risk of occurrence of other neoplasiaP Ghiorzo, P Ciotti, M Mantelli, et al.
Journal of Translational Medicine|February 15, 2020
Clinical, pathological and dermoscopic phenotype of MITF p.E318K carrier cutaneous melanoma patientsGiulia Ciccarese, Bruna Dalmasso, William Bruno, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 17, 2008
No evidence for linkage with melanoma in Italian melanoma-prone familiesKimberly F Kerstann, Porcia T Bradford, Robert Steighner, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 31, 2009
Pathological and molecular characteristics distinguishing contralateral metastatic from new primary breast cancerB Banelli, I Casciano, A Di Vinci, et al.
Pageof 15

Showing results (51-60 of 147) with videos related to

Sort By:
Pageof 15
Melanoma Research|November 10, 2007
The p.G23S CDKN2A founder mutation in high-risk melanoma families from Central ItalyFrancesca Gensini, Roberta Sestini, Mauro Piazzini, et al.
Journal of Translational Medicine|August 27, 2025
Identification of prognostic liquid biopsy biomarkers in patients with cutaneous squamous cell carcinoma treated with cemiplimabI Vanni, M Croce, L Pastorino, et al.
Genes, Chromosomes & Cancer|March 30, 2000
Mutation screening of the CDKN2A promoter in melanoma familiesM Harland, E A Holland, P Ghiorzo, et al.
Pigment Cell & Melanoma Research|November 6, 2008
CDKN2A mutations and MC1R variants in Italian patients with single or multiple primary melanomaL Pastorino, L Bonelli, P Ghiorzo, et al.
Plos One|September 7, 2012
Novel PTCH1 mutations in patients with keratocystic odontogenic tumors screened for nevoid basal cell carcinoma (NBCC) syndromeLorenza Pastorino, Annamaria Pollio, Giovanni Pellacani, et al.
Oncotarget|January 1, 2017
Heterogeneity and frequency of BRAF mutations in primary melanoma: Comparison between molecular methods and immunohistochemistryWilliam Bruno, Claudia Martinuzzi, Virginia Andreotti, et al.
International Journal of Cancer|October 3, 1999
Characterization of ligurian melanoma families and risk of occurrence of other neoplasiaP Ghiorzo, P Ciotti, M Mantelli, et al.
Journal of Translational Medicine|February 15, 2020
Clinical, pathological and dermoscopic phenotype of MITF p.E318K carrier cutaneous melanoma patientsGiulia Ciccarese, Bruna Dalmasso, William Bruno, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 17, 2008
No evidence for linkage with melanoma in Italian melanoma-prone familiesKimberly F Kerstann, Porcia T Bradford, Robert Steighner, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 31, 2009
Pathological and molecular characteristics distinguishing contralateral metastatic from new primary breast cancerB Banelli, I Casciano, A Di Vinci, et al.
Pageof 15